Trial intelligence / Profile preview

CBT-I vs Quetiapine for Residual Insomnia in Elderly

NCT00462618Phase 3Completed

Sponsor
Michael E. DeBakey VA Medical Center
Start
Apr 2007
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of quetiapine in Insomnia (2 arms), sponsored by Michael E. DeBakey VA Medical Center. Primary endpoint: Pittsburgh Sleep Quality Index at 12 weeks. Started Apr 2007; status: completed.

02

Drugs

quetiapine
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00462618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00462618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call